Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
EQS-News: ABIVAX / Key word: Study results Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis 17.04.2023 / 18:00... | April 17, 2023